de Vegt F - Search Results

1

Healthy donor effect: its magnitude in health research among blood donors.

Atsma F, Veldhuizen I, Verbeek A, de Kort W, de Vegt F. Atsma F, et al. Among authors: de vegt f, de kort w. Transfusion. 2011 Aug;51(8):1820-8. doi: 10.1111/j.1537-2995.2010.03055.x. Epub 2011 Feb 22. Transfusion. 2011. PMID: 21342203

2

The healthy donor effect: a matter of selection bias and confounding.

Atsma F, de Vegt F. Atsma F, et al. Among authors: de vegt f. Transfusion. 2011 Sep;51(9):1883-5. doi: 10.1111/j.1537-2995.2011.03270.x. Epub 2011 Jul 25. Transfusion. 2011. PMID: 21790637 Review. No abstract available.

3

Cardiovascular and demographic characteristics in whole blood and plasma donors: results from the Donor InSight study.

Atsma F, Veldhuizen I, de Vegt F, Doggen C, de Kort W. Atsma F, et al. Among authors: de vegt f, de kort w. Transfusion. 2011 Feb;51(2):412-20. doi: 10.1111/j.1537-2995.2010.02867.x. Epub 2010 Aug 30. Transfusion. 2011. PMID: 20804526

4

No supportive evidence for clinical benefit of routine follow-up in ovarian cancer: a Dutch multicenter study.

Geurts SM, van Altena AM, de Vegt F, Tjan-Heijnen VC, Massuger LF, van Dijck JA, Verbeek AL. Geurts SM, et al. Among authors: de vegt f. Int J Gynecol Cancer. 2011 May;21(4):647-53. doi: 10.1097/IGC.0b013e318212b87d. Int J Gynecol Cancer. 2011. PMID: 21543930

5

Entering a new era of body indices: the feasibility of a body shape index and body roundness index to identify cardiovascular health status.

Maessen MF, Eijsvogels TM, Verheggen RJ, Hopman MT, Verbeek AL, de Vegt F. Maessen MF, et al. Among authors: de vegt f. PLoS One. 2014 Sep 17;9(9):e107212. doi: 10.1371/journal.pone.0107212. eCollection 2014. PLoS One. 2014. PMID: 25229394 Free PMC article.

6

Cohort Profile: The Nijmegen Biomedical Study (NBS).

Galesloot TE, Vermeulen SH, Swinkels DW, de Vegt F, Franke B, den Heijer M, de Graaf J, Verbeek ALM, Kiemeney LALM. Galesloot TE, et al. Among authors: de vegt f. Int J Epidemiol. 2017 Aug 1;46(4):1099-1100j. doi: 10.1093/ije/dyw268. Int J Epidemiol. 2017. PMID: 28082374 Free PMC article. No abstract available.

7

[Aftercare in oncology--greater role for the general practitioner].

de Vegt F, van Dijck JA, van de Lisdonk EH, Verbeek AL. de Vegt F, et al. Ned Tijdschr Geneeskd. 2011;155(45):A4148. Ned Tijdschr Geneeskd. 2011. PMID: 22085581 Dutch.

8

Effect of routine follow-up after treatment for laryngeal cancer on life expectancy and mortality: results of a Markov model analysis.

Ritoe SC, de Vegt F, Scheike IM, Krabbe PF, Kaanders JH, van den Hoogen FJ, Verbeek AL, Marres HA. Ritoe SC, et al. Among authors: de vegt f. Cancer. 2007 Jan 15;109(2):239-47. doi: 10.1002/cncr.22401. Cancer. 2007. PMID: 17154185 Free article.

9

Considering early detection of relapsed ovarian cancer: a review of the literature.

Geurts SM, de Vegt F, van Altena AM, van Dijck JA, Tjan-Heijnen VC, Verbeek AL, Massuger LF. Geurts SM, et al. Among authors: de vegt f. Int J Gynecol Cancer. 2011 Jul;21(5):837-45. doi: 10.1097/IGC.0b013e31821bb88c. Int J Gynecol Cancer. 2011. PMID: 21697678 Review.

10

Impact of routine follow-up examinations on life expectancy in ovarian cancer patients: a simulation study.

Geurts SM, de Vegt F, van Altena AM, Tjan-Heijnen VC, Massuger LF, Adang EM, van Dijck JA, Verbeek AL. Geurts SM, et al. Among authors: de vegt f. Int J Gynecol Cancer. 2012 Sep;22(7):1150-7. doi: 10.1097/IGC.0b013e3182611451. Int J Gynecol Cancer. 2012. PMID: 22864333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters